LAURUSLABS

share price target: Brokerage retains Buy rating, sees 14% upside after Q1 results

Laurus Labs Share Price Target: Laurus Labs, a major pharmaceutical has delivered a decent performance in the first quarter ended April-June 2026. The company's profit rose 125 per cent, with its financial results exceeding market expectations and estimates. Following the strong operational performance, improving profitability and positive business outlook, a brokerage firm has retained its Buy rating on the stock and set a new target price of Rs 1,820, indicating an estimated 14 per cent upside potential from the current market price. Laurus Labs share price